When the medication isn't working
Semaglutide Not Working: Dose, Storage, and Product Checks
If semaglutide is not working the way you expected, the cause is often the dose step, the time on treatment, storage, or the product itself. This guide walks through each check and what to bring to your prescriber.
Last reviewed
The Vital angle
Vital logs each dose with the amount, strength, source type, injection site, and a note, so you can see exactly what you took and when. Your weight trend from Apple Health sits next to that dose history, which gives your prescriber a clear record when you ask why semaglutide is not working.
When people say semaglutide is not working, they usually mean one of three things: the scale has not moved, appetite feels the same as before, or the effect seemed to fade. Each has a different set of likely causes. This guide covers brand semaglutide (Wegovy® and Ozempic®) and compounded semaglutide, and it focuses on what you can check yourself and what to raise with your prescriber or pharmacist.
None of this replaces medical advice. Do not change, skip, or double a dose on your own. The goal is to arrive at your next appointment with a clear picture.
First, check where you are in the dose schedule
Semaglutide starts low on purpose. The Wegovy label begins at 0.25 mg once weekly for four weeks, then steps up every four weeks through 0.5 mg, 1 mg, and 1.7 mg before the usual maintenance dose of 2.4 mg. The label describes the early steps as initiation and escalation doses, not maintenance doses. Their main job is to let your gut adjust and to reduce nausea and other stomach side effects.
That means the first two to three months are not a fair test of the medication. If you are on 0.25 mg or 0.5 mg and see little change, that is common. If your prescriber held you at a lower step because of side effects, the timeline stretches further. For more on why early months look slow, see GLP-1 not working in the first month.
Questions to note for your prescriber:
- Which dose am I on now, and how many weeks have I been on it?
- Is the plan to keep increasing, or is this my intended maintenance dose?
- If side effects slowed my titration, what is the new timeline?
Give the trend enough time
In the STEP 1 trial, average weight loss on semaglutide 2.4 mg continued for more than a year before it levelled off around week 60 to 68. The curve was gradual, not a sudden drop. Individual results ranged widely around the average.
Daily weight moves one to three pounds from water, salt, and digestion alone. A week or two of flat readings does not tell you much. Compare four-week averages instead of single weigh-ins. If you lost steadily for months and then stalled, that is a different situation from no response at all; see weight loss plateaus and GLP-1 stopped working.
Check storage and handling
Semaglutide is a protein-based medicine, and heat or freezing can damage it. The Wegovy pen guide says to keep pens in the refrigerator at 36 °F to 46 °F (2 °C to 8 °C), never in the freezer. If needed, a pen can be kept between 46 °F and 86 °F (8 °C to 30 °C) for up to 28 days before the cap comes off, in its carton and away from light.
Situations to review:
- The medication arrived warm, or a shipping cold pack was fully melted.
- A pen or vial sat in a hot car, a sunny window, or checked luggage.
- Something froze at the back of the refrigerator.
- A pen went past its room-temperature window or its expiration date.
The FDA tells patients not to use an injectable GLP-1 that arrives warm or without enough refrigeration. If any of these apply, call your pharmacy before your next dose and ask whether the product is still usable. For more detail, see GLP-1 left out of the fridge and compounded GLP-1 vial storage.
If you use compounded semaglutide
Compounded semaglutide is not reviewed by the FDA for safety, effectiveness, or quality before it is sold. That does not mean every compounded product fails, but it adds variables that a brand pen does not have. Read compounded vs brand semaglutide for the background.
Points the FDA highlights:
- Dosing errors. Many compounded products come in multi-dose vials, and you measure each dose with a syringe. The FDA has received reports of people drawing the wrong amount, and of clinicians miscalculating doses. Confusion between milligrams, milliliters, and syringe units is one way this can happen.
- Different salt forms. The FDA says semaglutide sodium and semaglutide acetate are different active ingredients from the one in approved products, and it has no data that they behave the same.
- Unknown sources. Products sold online as "for research" or "not for human use" can contain the wrong amount of drug, or none.
- Vial age. The FDA generally advises discarding a multi-dose vial 28 days after first use, even if liquid remains, and using a new sterile needle and syringe for every dose.
Practical checks with a compounded vial:
- Read the label for the concentration in mg per mL.
- Ask the pharmacy to confirm, in writing, how many units on your syringe equal your prescribed dose.
- Confirm the pharmacy is state-licensed and that the product is not a salt form.
- Write down the vial's first-use date.
If the math does not match what you have been drawing, stop and call the pharmacy or prescriber before the next dose. Do not adjust the amount yourself.
Check the injection itself
A missed or partial dose can look like a medication that stopped working. With a pen, the common issues are removing it too soon, not holding it until the counter or window shows the dose is complete, or a pen that did not click. With a vial, air bubbles and leaks at the site can reduce the amount you get. Review injection technique and, for pen problems, Ozempic pen not clicking or Wegovy pen not injecting.
Missed weeks also add up. If you skipped or delayed doses, the label has specific rules on what to do, and restarting after a long gap may need a new plan from your prescriber. See missed GLP-1 dose.
Look at the rest of the picture
Semaglutide lowers appetite, but it does not set your intake for you. Over months, portions and snacks can creep back up without notice. A short period of honest food logging often shows more than another month of waiting. Protein and resistance training help protect muscle while you lose weight; see protein on GLP-1.
Other medicines and conditions can also slow weight loss. Some antidepressants, steroids, insulin, and certain diabetes medicines can push weight up. Thyroid problems, sleep loss, and perimenopause can all play a part. Your prescriber can review these.
What to bring to your appointment
A short, specific record helps your prescriber decide whether to adjust the plan, check for another cause, or consider a different medication. Bring:
- Your dose history: each dose, the date, and any missed or delayed weeks.
- Your weight trend over at least eight weeks, not a single number.
- The product details: brand or compounded, pharmacy name, concentration, lot number, and first-use date for vials.
- Side effects and when they happen in the week.
- Any new medicines or health changes.
Some people on semaglutide do not lose much weight even at the full dose. If that is your situation after a fair trial, your prescriber may discuss other options, including tirzepatide. See switching from semaglutide to tirzepatide for the questions to ask.
When to get care now
Get medical help right away if you have:
- Severe stomach pain that does not go away, with or without vomiting, sometimes spreading to your back.
- Swelling of your face, lips, tongue, or throat, or trouble breathing.
- Vomiting or diarrhea that stops you from keeping fluids down.
- Pain in the upper right stomach, fever, or yellow skin or eyes.
- Signs of low blood sugar if you also take insulin or a sulfonylurea.
- New or worse depression, or thoughts of harming yourself.
Wegovy® and Ozempic® are trademarks of Novo Nordisk A/S. Vital is independent and not affiliated with these companies.
Things to watch
Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.
Judging semaglutide at the starting dose
The label describes 0.25 mg, 0.5 mg, and 1 mg as initiation and escalation doses, not maintenance doses. Little change in the first two to three months is common and is not proof of non-response.
Unit confusion with compounded vials
The FDA has received reports of people drawing the wrong amount from multi-dose vials and of clinicians miscalculating doses. Confirm with the pharmacy how many syringe units equal your prescribed dose.
Semaglutide sodium or acetate salt forms
The FDA says these are different active ingredients from the one in approved products, with no data that they behave the same. Ask your pharmacy which form your product contains.
Product that arrived warm or was frozen
Heat and freezing can damage the medicine. The FDA tells patients not to use an injectable GLP-1 that arrives warm or without enough refrigeration. Call the pharmacy before using it.
Missed or partial doses
A pen removed too soon, a leak at the site, or skipped weeks can look like a medication that stopped working. A dose history shows whether the doses were actually taken in full.
Frequently asked questions
The most common reasons are being on a low starting dose, not enough time on treatment, missed or partial doses, storage problems, or a compounded product with dosing or quality issues. Review each with your prescriber or pharmacist before you assume non-response.
Appetite changes can start in the first few weeks, but the Wegovy schedule takes about 16 weeks to reach the usual maintenance dose. In the STEP 1 trial, average weight loss continued for more than a year before it levelled off.
The FDA does not review compounded semaglutide for quality before it is sold, and it has flagged dosing errors, salt forms, and products of unknown source. A compounded product can be fine, but you cannot confirm its strength the way you can with an approved pen.
Heat and freezing can damage it. Wegovy pens can stay between 46 °F and 86 °F for up to 28 days before the cap comes off. If a pen or vial got hotter than that, froze, or arrived warm, ask your pharmacy whether to use it.
Talk to your prescriber. Bring your dose history, an eight-week weight trend, and your product details. They can look for other causes, such as medicines or thyroid problems, and discuss other options.
No. Do not change your dose on your own. Dose changes need your prescriber, and taking more than prescribed raises the risk of serious stomach side effects and dehydration.
Sources
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration
- Wegovy (semaglutide) injection Prescribing Information · U.S. Food and Drug Administration
- Wegovy Pen Guide and Dosing Information · Novo Nordisk
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine
- How fast does semaglutide kick in · Mayo Clinic Diet
This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.
Track every shot, every change
Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.
More from the Library
Compounded vs Brand Semaglutide
Compounded semaglutide and brand-name Wegovy or Ozempic are not the same product. A clear-eyed look at the actual differences in regulation, formulation, cost, and risk.
Food Noise Coming Back on a GLP-1: End-of-Week Hunger and What to Track
Food noise coming back on a GLP-1 can follow the dose week, a dose step, stress, or a product change. Here is what is known, what to track for two to four weeks, and what to ask your prescriber.
Tirzepatide Medication Level Chart: Half-Life, Steady State, and Missed Doses
A tirzepatide medication level chart and a semaglutide level chart built from label half-lives, with tables for one dose, the build-up to steady state, the weekly rise and fall, and a missed dose.
GLP-1 Not Working in the First Month: What Is Normal
Little or no weight loss in the first month on a GLP-1 is common, because the starting doses are low by design. Here is what the first weeks are for, what to watch, and when to call your prescriber.